Fluoroquinolone and macrolide co-resistance in clinical isolates of Campylobacter species: a 15-year study in Karachi, Pakistan
EMHJ-Eastern Mediterranean Health Journal. 2010; 16 (12): 1226-1230
em Inglês
| IMEMR
| ID: emr-158591
ABSTRACT
Fluoroquinolone and macrolide antibiotics are generally considered as first-line drugs for the treatment of severe campylobacteriosis. This study was conducted to analyse the trend of erythromycin and ofloxacin resistance among Campyiobacter spp. isolated from stool specimens over a period of 15 years [1992-2007] at The Aga Khan University clinical laboratory in Karachi, Pakistan. A total of 83 396 stool specimens were processed, with a 14% isolation rate for enteric pathogens. The isolation rate of Campylobacter spp. was low during 1992-93 [6%-13%], peaked in 1996 [46%], then ranged from 20% to 40%. We report a rising trend in ofloxacin resistance, re-emergence of erythromycin resistance and indications of co-resistance to both drugs in clinical isolates of Campylobocter spp.
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Testes de Sensibilidade Microbiana
/
Estudos Retrospectivos
/
Macrolídeos
/
Fluoroquinolonas
/
Farmacorresistência Bacteriana
Limite:
Humanos
Idioma:
Inglês
Revista:
East Mediterr Health J.
Ano de publicação:
2010
Similares
MEDLINE
...
LILACS
LIS